跳至主要内容
临床试验/NCT00927992
NCT00927992已完成不适用

Liver Transplantation in Haemophilia Patients in Spain

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 11 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11
主要终点
Number of Participants Requiring Immunosuppressive Therapy After Liver Transplantation

研究概览

简要总结

This study will analyze survival and outcome of patients with severe haemophilia who undergo liver transplantation in Spain

详细描述

Probability Sample

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with haemophilia who underwent liver transplantation and who have been followed-up at any site in Spain.

排除标准

  • Patients without informed consent form.

结局指标

主要结局

Number of Participants Requiring Immunosuppressive Therapy After Liver Transplantation

时间窗: Post liver transplantation up to Month 3

Cyclosporine, corticosteroids, tacrolimus, mycophenolate mofetil, everolimus were considered as immunosuppressive therapy after liver transplantation.

Number of Participants With Acute Rejection of Liver Transplant

时间窗: Post liver transplantation up to Month 3

Any acute rejection of the liver transplant was clinically suspected and biopsy proven by central pathologist.

Number of Participants With Hepatitis C Viral Infection Recurrence After Liver Transplantation

时间窗: Post liver transplantation up to Month 3

Number of participants who had liver transplantation after cirrhosis due to hepatitis C virus (HCV) infection and experienced recurrence of HCV infection post liver transplantation.

Number of Participants Who Survived After Liver Transplantation

时间窗: Post liver transplantation up to Month 3

Number of participants who survived after liver transplantation was reported. The death reported was a result of acute-related transplantation complications and end-stage liver disease.

次要结局

  • Number of Participants Requiring Exogenous Clotting Factor Infusion During Liver Transplantation(Up to Day 5 post liver transplantation)
  • Dose of Exogenous Clotting Factors Used During Liver Transplantation(Up to Day 5 post liver transplantation)
  • Number of Participants With and Without Hemophilia Requiring Immunosuppressive Therapy, Had Acute Rejection, Hepatitis C Viral Infection Recurrence and Who Survived After Liver Transplantation(Post liver transplantation up to Month 3)

研究者

发起方
Wyeth is now a wholly owned subsidiary of Pfizer
申办方类型
Industry
责任方
Sponsor

相似试验